Aidapak Recalls Losartan Potassium Tablets Due to Labeling Mixup
Aidapak Services, LLC is recalling Losartan Potassium 25 mg tablets because they may be mislabeled as other medications. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a labeling mixup, which fits the 'Moderate' criteria for labeling errors without reported injuries.
Plain-English summary
Aidapak Services, LLC is recalling Losartan Potassium 25 mg tablets (NDC 16714058102) due to a labeling mixup. The source text indicates that the Losartan Potassium tablets may be potentially mislabeled as Docusate Sodium 250 mg capsules, Metoprolol Tartrate 50 mg tablets, Lactobacillus Acidophilus 35 Million tablets, or Oxybutynin Chloride tablets.
The recalled product consists of 448 tablets per unit. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. Specific pedigree codes and expiration dates are associated with the affected lots, including AD67989_7 (EXP: 5/28/2014), W003845 (EXP: 6/27/2014), W003899 (EXP: 6/27/2014), and AD22616_7 (EXP: 5/2/2014).
Consumers and healthcare providers should check their inventory for these specific NDCs and pedigree codes. If the product is found, it should be returned to the supplier or disposed of according to local regulations. Patients should consult their healthcare provider if they have questions about their medication.
The recalled product
- Product
- LOSARTAN POTASSIUM Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714058102
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 448
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- LOSARTAN POTASSIUM Tablet
- 25 mg has the following codes Pedigree: AD67989_7
- EXP: 5/28/2014
- Pedigree: W003845
- EXP: 6/27/2014
- Pedigree: W003899
- Pedigree: AD22616_7
- EXP: 5/2/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Losartan Potassium Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereLosartan Potassium Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateLosartan Potassium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Methocarbamol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Levothyroxine Sodium Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModeratePotassium Acid Phosphate Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-29